Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer

Cisplatin (DDP) is currently one of the most commonly used chemotherapeutic drugs for treating ovarian and lung cancer. However, resistance to cisplatin is common and it often leads to therapy failure. In addition, the precise mechanism of cisplatin resistance is still in its infancy. In this study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Zheng, Wujian, Feng, Qi, Liu, Jiao, Guo, Yanke, Gao, Lvfen, Li, Ruiman, Xu, Meng, Yan, Guizhen, Yin, Zhinan, Zhang, Shuai, Liu, Shuangping, Shan, Changliang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5491617/
https://ncbi.nlm.nih.gov/pubmed/28713273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00421
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados